Case Reports of Cancer Therapies - Akbar Khan, MD (2021 Conference) (LDN, low dose naltrexone)

Dr. Khan believes in integrative care, combining allopathic and naturopathic therapies. They treat all types of cancer and people of all ages, with a focus on non-toxic therapy, and quality of life.

Microbiome Medicine: Clinical Correlations From The Trenches - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

In her presentation, Dr. Zielsdorf shares the importance and complexity of the human microbiome and best practices (from her own clinical experience) for restoring the gut microbiome and intestinal barrier.

Infection - Stefanie Werner, NMD (2021 Conference) (LDN, low dose naltrexone)

SIBO - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Opiate Receptor Drugs – To Cycle or Not to Cycle Dosing? - Paul Anderson, NMD (2021 Conference) (LDN, low dose naltrexone)

Mold toxicity - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Atopic Dermatitis - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Atopic dermatitis is a hereditary skin disorder, and the most common form of eczema. Dr. Smith reviews the pathophysiology and diagnostic criteria for atopic dermatitis, as well as some causes.

Mast Cell Activation Syndrome (MCAS) - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

How to treat pathologic cell behaviors - Mark Cooper, PhD (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

The role of immune modulation in cancer - Professor Angus Dalgleish (2021 Conference) (LDN, low dose naltrexone)